Clinical Trial Update: Signal TrAnsduction Pathway Activity Analysis in OVarian cancER [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update focusing on signal transduction pathway activity analysis in recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Gynaecologisch Oncologisch Centrum Zuid | Conditions: Recurrent Ovarian Cancer, Signal Transduction Pathway Deregulation | Phase 2, Phase 3 | Status: RECRUITING